Frontal fibrosing alopecia (FFA) is a scarring form of hair loss that slowly moves the front hairline backward and often thins or erases the eyebrows. Hair lost to FFA does not grow back, so treatment aims to stop it spreading. In 2025 and early 2026, two expert groups published the first formal consensus guidance on how to do that, and they agree on more than they disagree.
What FFA is, and why it isn't an ordinary receding hairline
FFA is considered a variant of lichen planopilaris, an inflammatory condition in which the immune system attacks the stem-cell area of the hair follicle. Once that area is destroyed, the follicle is replaced by scar tissue. According to the American Academy of Dermatology, most people who develop it are women, often after menopause, though it can begin earlier and men can get it too. The AAD notes that without treatment, the hair loss tends to spread.
Because the main sign is a hairline moving back, FFA is easy to mistake for pattern hair loss. The differences matter, because the treatments are not the same.
| Feature | Frontal fibrosing alopecia | Pattern hair loss (male or female) |
|---|---|---|
| Hairline skin | Pale, smooth, shiny band with no visible follicle openings | Normal skin; follicles still present, just miniaturized |
| Eyebrows | Often thinned or lost, sometimes before the scalp changes | Usually unaffected |
| Around remaining hairs | Redness and scale at the follicle base on close inspection | No inflammation |
| Symptoms | Itching, burning or tenderness are common | Usually none |
| Other clues | Small skin-colored bumps on the face; isolated "lonely" hairs left in the bare band; loss of body hair | Gradual thinning at temples, crown or part line |
| Can hair regrow? | Not in scarred areas; goal is to halt progression | Often partly, with medical treatment |
If you have been tracking a receding hairline against the Norwood scale, eyebrow loss or an itchy, shiny strip of skin at the front is the signal to stop self-assessing and see a dermatologist (our receding hairline guide covers the ordinary causes).
The two new consensus documents
Until recently, FFA treatment rested on case series and expert habit. Two Delphi consensus exercises (a structured method in which experts rate statements over several rounds until agreement is measured) have now formalized it:
- SOFFIA 2024, an international statement from the frontal fibrosing alopecia expert alliance, published in the Journal of the European Academy of Dermatology and Venereology in 2025. Of 69 invited hair specialists, 61 completed the first round, and only 204 of 365 questions reached the 66% agreement threshold. (Meah, Li et al., JEADV 2025)
- The Spanish trichology group (GETO-AEDV) consensus, published in Actas Dermo-Sifiliográficas (January 2026 issue). A panel of 22 Spanish dermatologists rated 106 statements over two rounds in early 2025 and agreed on 103. (Saceda-Corralo et al., 2026)
Neither is a clinical trial; both are structured expert opinion, the best guidance available while large trials are lacking.
Where the experts agree
Calm the inflammation on the skin first
Both groups put a strong (high- or very-high-potency) topical corticosteroid first. SOFFIA advises daily use for three to six months and not beyond six months; the Spanish group pairs it with a topical calcineurin inhibitor such as tacrolimus. SOFFIA is explicit that these treatments help halt progression but do not regrow hair.
Steroid injections for active areas
Both support injections of triamcinolone into inflamed hairline areas. SOFFIA suggests 5 mg/mL for the scalp and 2.5 mg/mL for eyebrows every six to eight weeks, mainly in early disease. The Spanish panel discourages concentrations of 8 mg/mL or higher and recommends very small volumes per injection, since injected steroids can thin the skin.
5-alpha-reductase inhibitors as the main oral option
Both documents name 5-alpha-reductase inhibitors (5-ARIs) as the preferred first systemic medicine. SOFFIA lists finasteride 2.5 mg or dutasteride 0.5 mg daily; the Spanish group favors dutasteride 0.5 mg daily as first choice because it is more potent with a similar safety profile. Using these drugs for FFA is off-label, and neither is suitable during pregnancy or for anyone who may become pregnant, because they can affect the development of a male fetus. That is a key point, since many people with FFA are women. We cover the evidence and side effects in detail in Dutasteride for Hair Loss.
Hydroxychloroquine for persistent activity
Hydroxychloroquine, an anti-inflammatory medicine also used for lupus, is the second-line oral choice in both documents, aimed at people with ongoing inflammation or worrying features. SOFFIA cites 5 mg/kg/day; the Spanish group starts at 4.5 mg/kg/day and stresses eye monitoring, since long-term use can damage the retina.
Little evidence for JAK inhibitors yet
JAK inhibitors have transformed treatment of alopecia areata, so people naturally ask about them for FFA. As of November 2026, neither group found enough evidence to recommend them: SOFFIA reached no consensus, and the Spanish panel notes that no trials have tested oral JAK inhibitors in FFA.
Where they disagree
| Question | SOFFIA 2024 (international) | Spanish GETO-AEDV (2026) |
|---|---|---|
| Sunscreen | Don't stop sunscreen altogether, and don't switch between chemical and mineral types on that basis; use hats as added protection. Avoiding sunscreen on the forehead and brows came close to, but did not reach, consensus. | Use sunscreens with mineral (inorganic) filters; avoid soluble organic filters and cosmetics containing benzyl salicylate. |
| Preferred 5-ARI | Finasteride 2.5 mg or dutasteride 0.5 mg | Dutasteride 0.5 mg first |
| Disease stable before a transplant | Ideally at least 24 months with no activity | At least 12 months, with no inflammation on trichoscopy, and a small area (under 1,500 grafts) |
Why sunscreen is such a sticking point
The sunscreen debate traces back to a 2016 UK questionnaire study of 105 women with FFA and 100 matched controls, which found that sunscreen use was significantly more common in the FFA group (Aldoori et al., BJD 2016). It was a small study that relied on people remembering their past product use, it could not show cause and effect, and other researchers questioned whether the association held up statistically. That uncertainty is exactly why the two panels landed in different places. What neither says is that you should abandon sun protection, which protects against skin cancer.
What genetics adds
A 2019 genome-wide association study of 1,044 women with FFA and 4,145 controls from the UK and Spain found four risk regions (Tziotzios et al., Nature Communications 2019). The strongest was the immune gene variant HLA-B*07:02, carried with roughly five times higher odds of FFA. Another, in the gene CYP1B1, is involved in breaking down estrogens and possibly outside chemicals. The authors suggested that something women are exposed to more often might interact with this gene, but their own blood-chemical analysis found no clear culprit. The picture so far is an immune condition in genetically predisposed people, with any environmental trigger still unidentified.
Transplants, eyebrows and camouflage
Because FFA scars the follicle, people often ask about surgery. Both panels say a transplant is not a first-line option and should only be considered after a long period of proven inactivity. SOFFIA's experts came close to agreeing that more than half of transplanted hairs are typically lost beyond five years, and they advise continuing medical treatment indefinitely, since surgery may reactivate the disease. Anyone weighing an eyebrow transplant or hairline surgery for women should raise FFA with the surgeon first. SOFFIA also recommends discussing cosmetic camouflage with every patient, which can make a real difference while treatment takes effect.
FAQ
Can hair grow back after frontal fibrosing alopecia?
Not in areas that have scarred. Hairs that are thinned but still alive may improve once inflammation is controlled, and SOFFIA notes topical minoxidil may help some regrowth, but the main goal of treatment is to stop further loss.
Does FFA stop on its own?
It can slow or go quiet over time, but its course is unpredictable, which is why both consensus groups recommend regular checkups with photos and trichoscopy to track activity.
Is FFA linked to thyroid disease?
Thyroid disease has been reported more often in people with FFA. The Spanish consensus recommends a thyroid blood test (TSH) for everyone diagnosed.
For more of the science behind hair loss, browse Hairloss Labs, read our clinical look at female pattern hair loss, or ask us a question.